Preview

Ateroscleroz

Advanced search

Myocardial state in overweight individuals after coronary revascularization

https://doi.org/10.52727/2078-256X-2023-19-2-145-153

Abstract

Heart and vascular diseases, or cardiovascular diseases (CVDs), have remained relevant for many decades and remain the most serious health problem in many countries around the world, including Kazakhstan. Experts from the World Health Organization (WHO) predict that by 2030 death from CVD may occur in 23.6 million people of working age. The widespread use of reconstructive and interventional methods, ensuring the restoration of blood flow in the myocardium, has made progress in the treatment of cardiovascular diseases. At the same time, serious problems remain during the reperfusion period at various stages of rehabilitation. The purpose of the review was to analyze the results of studies on the state of the myocardium in overweight individuals, especially after undergoing coronary artery surgery. The depth of the sample of literary sources was 20 years.

About the Authors

A. N. Seytekova
Medical University of Karaganda
Kazakhstan

 

40, Gogol str., Karaganda



V. B. Molotov-Luchanskiy
Medical University of Karaganda
Kazakhstan

Aizhan N. Seytekova, doctoral student of the 3rd year of study in the specialty «Medicine»

40, Gogol str., Karaganda



References

1. Electronic resource. https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causesof-death (In Russ.)

2. Shpagina O.V., Bondarenko I.Z. The «Obesity Par adox» is another look at the problem of cardiovas cular diseases. Literature review. Obesity and Metabolism, 2016; (4): 4–9. (In Russ.)

3. Berdygaliev A.B., Chuenbekova A.B., Kaynarbayeva M.S., Bykybayeva S.A., Sergeantova G.N., Askarov D.M. Studying the prevalence of overweight and obesity among women in Kazakhstan. Bulletin of KazNMU, 2015; (1): 409–413. (In Russ.)

4. Electronic resource. https://www.who.int/europe/ru/news/item/03-05-2022-obesity-causes-cancer-and-is-major-determinant-of-disability-and-death--warns-new-who-report(In Russ.)

5. Razina A.O., Runenko S.D., Achkasov E.E. The problem of obesity: current trends in Russia and in the world. Bull. of the Russian Academy of Medical Sciences, 2016; 71 (2): 154–159 (In Russ.)

6. Bardymova T.P., Mikhaleva O.G. Berezina M.V. A modern view on the problem of obesity. Bulletin of the All-Russian Scientific Research Center of the Russian Academy of Medical Sciences, 2011; 81: 5. (In Russ.)

7. Razina A.O., Achkasov E.E. Obesity: a modern view of the problem. Obesity and Metabolism, 2016; 13 (1): 3–8. (In Russ.)

8. Kolosnitsyna M.G., Kulikova O.A. Socio-economic factors and consequences of overweight. Demographic Review, 2018; 5 (4): 92–124. (In Russ.)

9. Rachel Harrison. «Obesity paradox» not found measu ring new cases if cardiovascular disease. J. LOS ONE, 2017; (12): 14–16.

10. Mendis S., Puska P., Norrving B. World Atlas of Prevention and Control of Cardiovascular Diseases. World Health Organization. Geneva, 2013. (In Russ.)

11. Antonopoulos А., Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovascular. Res., 2017; 113: 1074–1086. doi: 10.1093/cvr/cvx106

12. Sharma A., Vallakati А., Einstein A.J. Relationship of Body Mass Index with Total Mortality, Cardiovascular Mortality, and Myocardial Infarction After Coronary Revascularization. Evidence from a Metaanalysis. Mayo Clin. Proc., 2014; 89 (8): 1080–1100. doi: 10.1016/j.mayocp.2014.04.020

13. Barth S., Zacher В., Reinecke Н. Decreasing incidence of coronary heart disease in extreme obesity (BMI ? 40). A single centre experience. Obes. Res. Clin. Pract., 2017; 11 (4): 435–444. doi: 10.1016/j.orcp.2016.08.007

14. Drapkina O.M., Korneeva O.M., Palatkina L.O. Adipokines and cardiovascular diseases: pathogenetic parallels and therapeutic parallels. Arterial Hypertension, 2011; 17 (3): 202–211. (In Russ.)

15. Dashutina S.Yu., Peretolchina S.Yu., Barats S.S., Serebrennikov V.A. Structural and geometric left ventricular remodeling and systolo-diastolic parameters of intracardiac hemodynamics in isolated obesity. Rus. J. Cardiol., 2005; (4): 42–46. (In Russ.)

16. Postoeva A.V., Dvoryashina I.V., Bakhtina Z.E., Eliseeva I.V. Analysis of left ventricular hypertrophy predictors in women with different levels of obesity. Obesity and Metabolism, 2015; 12 (4): 34–41. (In Russ.)

17. Rashid M.A., Qureshi B.A., Ahmed N., Sherwani M.A. Impact of body mass index on left ventricular mass. J. Ayub Med. College, 2017; 26 (2): 167–169.

18. Miklishanskaya S.V., Mazur N.A., Solomasova L.V., Chigineva V.V. «The obesity paradox» and the degree of its proof. Therapeutic Archive, 2020; 92 (4): 84–90. (In Russ.)

19. Naganuma T., Chieffo А., Meliga Е. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc. Interv., 2014; 7: 354–361.

20. Qin Q., Qian J., Wu X. et al. A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease. Clin. Cardiol., 2013; 36: 54–60.

21. Serruys P.W., Ong A.T., van Herweden L.A. Five – year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease the final analysis of the arterial revascularization therapies study (ARTS). Randomized trial. J. Am. Coll. Cardiol., 2005; 46 (4): 575–581.

22. Califf R.M. Stenting or surgery. An opportunity to do it right. J. Am. Coll. Cardiol., 2005; 46: 589–591.

23. O’Neil W.W., Grines C.L. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomized controlled trial. Lancet, 2002; 360: 956–970.

24. Rodriguez A.E., Baldi J., Pereira C.F. Five-year follow – up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II). J. Am. Coll. Cardiol., 2005; 46: 582–598.

25. Rodriguez A.E., Bernardy V., Navia J. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II): 30-day and one – year follow-up results. ERACI II Investigators. J. Am. Coll. Cardiol., 2001; 37: 51–58.

26. Fergusson T.B.Jr., Hammfill B.G., Peterson E.D. A decade of change – risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from theSTS National Database-Commityandthe Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann. Thorac. Surg., 2002; 73: 480–489.

27. Hueb W., Soares P.R., Gersh B.J. The medicine, angioplasty, or surgery study (MASS-II): a randomizedcontrolledclinical trial ofthreetherapeutic stagesfor multivessel coronary artery disease. J. Am. Coll. Cardiol., 2004; 43: 1743–1751.

28. Raimondo Ascione, Barnaby C. Reeves, Karen Rees. Gianni D. Angelini. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients. Circulation, 2002; 106: 1764–1770.

29. Aronov D., Bubnova M., Iosseliani D., Orekhov A. Clinical Efficacy of а Medical Centre- and Home-based Cardiac Rehabilitation Program for Patients with Coronary Heart Disease After Coronary Bypass Graft Surgery. Arch. Med. Res., 2019; 50 (3): 122–132.

30. Chesnokova N.P., Ponukalina E.V., Bizenkova M.N. Molecular and cellular mechanisms of cytotoxic action of hypoxia. Pathogenesis of hypoxic necrobiosis. Modern. High-tech. Technol., 2006; 7: 32–40. (In Russ.)

31. Bokeria L.A., Chicherin I.N. The nature and clinical significance of “new ischemic syndromes”. M.: Publishing House of the A.N. Bakulev National Research Center of the Rus. Acad. Med. Sci., 2007. P. 302. (In Russ.)

32. Parkhomenko A.N., Bryl Zh.V. Pathophysiological mechanisms of ischemic and reperfusion myocardial injury in experimental studies. Ukrainian Cardiol. J., 2000; 5-6: 95–99. (In Russ.)

33. Lyubimov A.V., Shabanov P.D. Ischemia, reperfusion and preconditioning: traditional and new approaches for treatment of myocardial infarction. Clin. Pharmacol. and Drug Ther. Rev., 2016; 14 (3): 3–11.

34. Venetucci L.A., Trafford A.W., O’Neill S.C. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc. Res., 2008; 77 (2): 285–292.

35. Hausenloy D.J., Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J. Mol. Cell. Cardiol., 2003; 35 (4): 339–341.

36. Perrelli M.G., Pagliaro Р., Penna С. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J. Cardiol., 2011; 3 (9): 186–200.

37. Parkhomenko A.N. The phenomenon of unrecoverable blood flow in patients with acute coronary syndrome and possible ways to improve tissue perfusion. Ukrainian Cardiol. J., 2007; 5: 17–25. (In Russ.)

38. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med., 2006; 3 (9): 499–506.

39. Jaffe R., Charron Т., Puley G., Dick А., Strauss B.H. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 2008; 117 (24): 3152–3156.

40. Choi C.J., HajiMomenian S., Dimaria J.M. Infarct involution and improved function during healing ofacute myocardial infarction: the role of microvascular obstruction. J. Cardiovasc. Magn. Reson., 2004; 6 (4): 917–925.

41. de Waha S., Desch S., Eitel I. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after STelevation myocardial infarction: a comparison with traditional prognostic markers. Eur. Heart J., 2010; 31 (21): 2660–2668.

42. Yagudin T.A., Shabanova A.T., Ishmetov V.Sh., Hong-Yu. Liu. The effect of ischemic conditioning on the contractile function of the myocardium in ischemic and reperfusion injuries of the myocardium. Med. Bull. Bashkortostan, 2019; 1 (79): 86–98.(In Russ.)

43. Xu X.J.., Gauthier M.-S., Hess D.T. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J. Lipid. Res., 2012; 53 (4): 792–801. doi: 10.1194/jlr.P022905

44. Аrbownik-Lewinska M., Szosland J., Kokoszko-Bilska А. Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol. Lett., 2012; 33 (4): 453–461.

45. Agarwal A., Aziz N., Rizk В. Studies on Women’s Health. NewYork: Humana Press, 2013. P. 33–60. doi: https://doi.org/10.1007/978-1-62703-041-0

46. Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol, Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010

47. Melnikova Yu.S., Makarova T.P. Endothelial dysfunction as a central link in the pathogenesis of chronic diseases. Kazan Med. J., 2015; 96 (4): 659–665. doi: 10.17750/KMJ2015-659(In Russ.)

48. Mammadova F.I. The effect of oxidative stress on the state of the endothelium in patients with heart failure and type 2 diabetes mellitus. Kazan Med. J., 2020; 101 (1): 13–17. doi: 10.17816/KMJ2020-13(In Russ.)

49. Wenceslau C.F., McCarthy C.G., Szasz T. et al. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol. Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010

50. Badoyan A.G., Gorgulko A.P., Khelimsky D.A., Krestyaninov O.V., Bergen T.A., Naydenov R.A., Baranov A.A. Role of collateral circulation in maintaining and restoring the left ventricular function and modern methods for its assessment. Rus. J. Cardiol., 2022; 27 (8): 5164. https://doi.org/10.15829/1560-4071-2022-5164 (In Russ.)

51. Antman E.M., Anbe D.T., Armstrong P.W. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation, 2004; 110 (9): 282–292.

52. Bautin A.E., Grebenchikov О.А., Eremenko А.А. et al. Adjuvant Cardioprotection in Cardiac Patients. Moscow: OOO «RIA “FarmEtika”» Publ., 2017. Р. 226.

53. Aronov D.M., Bubnova M.G. Problems of introduction of a new cardiorehabilitation system in Russia. Rus. J. Cardiol., 2013; 3 (4): 102.

54. Cardio mastic. 2016; 7: 3–4. www.con-med.ru. (In Russ.)

55. Vasyuk Yu.A., Shkolnik E.L. Modern possibilities and limitations of echocardiography in diseases of the cardiovascular system. Rus. J. Cardiol., 2013; 4 (102): 28–32. (In Russ.)

56. Rudski L.G., Lai W.W., Afilalo J. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults. A Report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr., 2010; 23: 685–713.

57. Lang R.M., Bierig М. Recommendations for chamber quantification. Eur. J. Echocardiogr., 2006; 7: 79–108.

58. Oh J.K., Seward J.B., Tajik A.J. The Echo Manual. Third edition. Lippincott Williams & Wilkins, 2007.

59. Vasyuk Y.A., Kozin А.А. et al. Features of diastolic function and remodeling of the left ventricle in patients with arterial hypertension and ischemic heart disease. J. Cardiac. Failure, 2003; 4 (4): 190–193.

60. Harvey Feigenbaum. Echocardiography; trans. edited by V.V. Mitkov. 5th ed. Moscow: Vidar Publ., 1999. (In Russ.)

61. Nagueh S.F., Appleton C.P., Gillebert T.C. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr., 2009; 10 (2): 65–93.


Review

For citations:


Seytekova A.N., Molotov-Luchanskiy V.B. Myocardial state in overweight individuals after coronary revascularization. Ateroscleroz. 2023;19(2):145-153. (In Russ.) https://doi.org/10.52727/2078-256X-2023-19-2-145-153

Views: 175


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-256X (Print)
ISSN 2949-3633 (Online)